Report Detail
Global DNA Repair Drugs Market Insights and Forecast to 2026
- RnM4133630 |
- 13 August, 2020 |
- Global |
- 152 Pages |
- QYResearch |
- Pharma & Healthcare
DNA Repair Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global DNA Repair Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the DNA Repair Drugs market is segmented into
PARP Inhibitors
Other
Segment by Application, the DNA Repair Drugs market is segmented into
Oncological
Stroke
Regional and Country-level Analysis
The DNA Repair Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the DNA Repair Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and DNA Repair Drugs Market Share Analysis
DNA Repair Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in DNA Repair Drugs business, the date to enter into the DNA Repair Drugs market, DNA Repair Drugs product introduction, recent developments, etc.
The major vendors covered:
4SC AG
ARCAGY/ GINECO GROUP
Bristol Myers Squibb
British Columbia Cancer Agency
Cambridge University Hospitals NHS Foundation Trust
Genentech
Georgetown University
German Breast Group
GlaxoSmithKline
Jiangsu Hengrui Medicine
Johnson & Johnson
Jonsson Comprehensive Cancer Center
Karyopharm Therapeutics
KuDOS Pharmaceuticals
National Health Service
National Institutes of Health
Tesaro
1 Study Coverage
- 1.1 DNA Repair Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key DNA Repair Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global DNA Repair Drugs Market Size Growth Rate by Type
- 1.4.2 PARP Inhibitors
- 1.4.3 Other
- 1.5 Market by Application
- 1.5.1 Global DNA Repair Drugs Market Size Growth Rate by Application
- 1.5.2 Oncological
- 1.5.3 Stroke
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global DNA Repair Drugs Market Size, Estimates and Forecasts
- 2.1.1 Global DNA Repair Drugs Revenue 2015-2026
- 2.1.2 Global DNA Repair Drugs Sales 2015-2026
- 2.2 Global DNA Repair Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global DNA Repair Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global DNA Repair Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global DNA Repair Drugs Competitor Landscape by Players
- 3.1 DNA Repair Drugs Sales by Manufacturers
- 3.1.1 DNA Repair Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 DNA Repair Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 DNA Repair Drugs Revenue by Manufacturers
- 3.2.1 DNA Repair Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 DNA Repair Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global DNA Repair Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by DNA Repair Drugs Revenue in 2019
- 3.2.5 Global DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 DNA Repair Drugs Price by Manufacturers
- 3.4 DNA Repair Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 DNA Repair Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers DNA Repair Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into DNA Repair Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global DNA Repair Drugs Market Size by Type (2015-2020)
- 4.1.1 Global DNA Repair Drugs Sales by Type (2015-2020)
- 4.1.2 Global DNA Repair Drugs Revenue by Type (2015-2020)
- 4.1.3 DNA Repair Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global DNA Repair Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global DNA Repair Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global DNA Repair Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 DNA Repair Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global DNA Repair Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global DNA Repair Drugs Market Size by Application (2015-2020)
- 5.1.1 Global DNA Repair Drugs Sales by Application (2015-2020)
- 5.1.2 Global DNA Repair Drugs Revenue by Application (2015-2020)
- 5.1.3 DNA Repair Drugs Price by Application (2015-2020)
- 5.2 DNA Repair Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global DNA Repair Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global DNA Repair Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global DNA Repair Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America DNA Repair Drugs by Country
- 6.1.1 North America DNA Repair Drugs Sales by Country
- 6.1.2 North America DNA Repair Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America DNA Repair Drugs Market Facts & Figures by Type
- 6.3 North America DNA Repair Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe DNA Repair Drugs by Country
- 7.1.1 Europe DNA Repair Drugs Sales by Country
- 7.1.2 Europe DNA Repair Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe DNA Repair Drugs Market Facts & Figures by Type
- 7.3 Europe DNA Repair Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific DNA Repair Drugs by Region
- 8.1.1 Asia Pacific DNA Repair Drugs Sales by Region
- 8.1.2 Asia Pacific DNA Repair Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific DNA Repair Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific DNA Repair Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America DNA Repair Drugs by Country
- 9.1.1 Latin America DNA Repair Drugs Sales by Country
- 9.1.2 Latin America DNA Repair Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America DNA Repair Drugs Market Facts & Figures by Type
- 9.3 Central & South America DNA Repair Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa DNA Repair Drugs by Country
- 10.1.1 Middle East and Africa DNA Repair Drugs Sales by Country
- 10.1.2 Middle East and Africa DNA Repair Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa DNA Repair Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa DNA Repair Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 4SC AG
- 11.1.1 4SC AG Corporation Information
- 11.1.2 4SC AG Description and Business Overview
- 11.1.3 4SC AG Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 4SC AG DNA Repair Drugs Products Offered
- 11.1.5 4SC AG Related Developments
- 11.2 ARCAGY/ GINECO GROUP
- 11.2.1 ARCAGY/ GINECO GROUP Corporation Information
- 11.2.2 ARCAGY/ GINECO GROUP Description and Business Overview
- 11.2.3 ARCAGY/ GINECO GROUP Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 ARCAGY/ GINECO GROUP DNA Repair Drugs Products Offered
- 11.2.5 ARCAGY/ GINECO GROUP Related Developments
- 11.3 Bristol Myers Squibb
- 11.3.1 Bristol Myers Squibb Corporation Information
- 11.3.2 Bristol Myers Squibb Description and Business Overview
- 11.3.3 Bristol Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Bristol Myers Squibb DNA Repair Drugs Products Offered
- 11.3.5 Bristol Myers Squibb Related Developments
- 11.4 British Columbia Cancer Agency
- 11.4.1 British Columbia Cancer Agency Corporation Information
- 11.4.2 British Columbia Cancer Agency Description and Business Overview
- 11.4.3 British Columbia Cancer Agency Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 British Columbia Cancer Agency DNA Repair Drugs Products Offered
- 11.4.5 British Columbia Cancer Agency Related Developments
- 11.5 Cambridge University Hospitals NHS Foundation Trust
- 11.5.1 Cambridge University Hospitals NHS Foundation Trust Corporation Information
- 11.5.2 Cambridge University Hospitals NHS Foundation Trust Description and Business Overview
- 11.5.3 Cambridge University Hospitals NHS Foundation Trust Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Products Offered
- 11.5.5 Cambridge University Hospitals NHS Foundation Trust Related Developments
- 11.6 Genentech
- 11.6.1 Genentech Corporation Information
- 11.6.2 Genentech Description and Business Overview
- 11.6.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Genentech DNA Repair Drugs Products Offered
- 11.6.5 Genentech Related Developments
- 11.7 Georgetown University
- 11.7.1 Georgetown University Corporation Information
- 11.7.2 Georgetown University Description and Business Overview
- 11.7.3 Georgetown University Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Georgetown University DNA Repair Drugs Products Offered
- 11.7.5 Georgetown University Related Developments
- 11.8 German Breast Group
- 11.8.1 German Breast Group Corporation Information
- 11.8.2 German Breast Group Description and Business Overview
- 11.8.3 German Breast Group Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 German Breast Group DNA Repair Drugs Products Offered
- 11.8.5 German Breast Group Related Developments
- 11.9 GlaxoSmithKline
- 11.9.1 GlaxoSmithKline Corporation Information
- 11.9.2 GlaxoSmithKline Description and Business Overview
- 11.9.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 GlaxoSmithKline DNA Repair Drugs Products Offered
- 11.9.5 GlaxoSmithKline Related Developments
- 11.10 Jiangsu Hengrui Medicine
- 11.10.1 Jiangsu Hengrui Medicine Corporation Information
- 11.10.2 Jiangsu Hengrui Medicine Description and Business Overview
- 11.10.3 Jiangsu Hengrui Medicine Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Jiangsu Hengrui Medicine DNA Repair Drugs Products Offered
- 11.10.5 Jiangsu Hengrui Medicine Related Developments
- 11.1 4SC AG
- 11.1.1 4SC AG Corporation Information
- 11.1.2 4SC AG Description and Business Overview
- 11.1.3 4SC AG Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 4SC AG DNA Repair Drugs Products Offered
- 11.1.5 4SC AG Related Developments
- 11.12 Jonsson Comprehensive Cancer Center
- 11.12.1 Jonsson Comprehensive Cancer Center Corporation Information
- 11.12.2 Jonsson Comprehensive Cancer Center Description and Business Overview
- 11.12.3 Jonsson Comprehensive Cancer Center Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Jonsson Comprehensive Cancer Center Products Offered
- 11.12.5 Jonsson Comprehensive Cancer Center Related Developments
- 11.13 Karyopharm Therapeutics
- 11.13.1 Karyopharm Therapeutics Corporation Information
- 11.13.2 Karyopharm Therapeutics Description and Business Overview
- 11.13.3 Karyopharm Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Karyopharm Therapeutics Products Offered
- 11.13.5 Karyopharm Therapeutics Related Developments
- 11.14 KuDOS Pharmaceuticals
- 11.14.1 KuDOS Pharmaceuticals Corporation Information
- 11.14.2 KuDOS Pharmaceuticals Description and Business Overview
- 11.14.3 KuDOS Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 KuDOS Pharmaceuticals Products Offered
- 11.14.5 KuDOS Pharmaceuticals Related Developments
- 11.15 National Health Service
- 11.15.1 National Health Service Corporation Information
- 11.15.2 National Health Service Description and Business Overview
- 11.15.3 National Health Service Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 National Health Service Products Offered
- 11.15.5 National Health Service Related Developments
- 11.16 National Institutes of Health
- 11.16.1 National Institutes of Health Corporation Information
- 11.16.2 National Institutes of Health Description and Business Overview
- 11.16.3 National Institutes of Health Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 National Institutes of Health Products Offered
- 11.16.5 National Institutes of Health Related Developments
- 11.17 Tesaro
- 11.17.1 Tesaro Corporation Information
- 11.17.2 Tesaro Description and Business Overview
- 11.17.3 Tesaro Sales, Revenue and Gross Margin (2015-2020)
- 11.17.4 Tesaro Products Offered
- 11.17.5 Tesaro Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 DNA Repair Drugs Market Estimates and Projections by Region
- 12.1.1 Global DNA Repair Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global DNA Repair Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America DNA Repair Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: DNA Repair Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: DNA Repair Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: DNA Repair Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe DNA Repair Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: DNA Repair Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: DNA Repair Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: DNA Repair Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific DNA Repair Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: DNA Repair Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: DNA Repair Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: DNA Repair Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America DNA Repair Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: DNA Repair Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: DNA Repair Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: DNA Repair Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa DNA Repair Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: DNA Repair Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: DNA Repair Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: DNA Repair Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key DNA Repair Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 DNA Repair Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on DNA Repair Drugs. Industry analysis & Market Report on DNA Repair Drugs is a syndicated market report, published as Global DNA Repair Drugs Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of DNA Repair Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
